...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Differences in anthropometric parameters and the IFG-I-IGFBP3 axis between liver and renal transplant children.
【24h】

Differences in anthropometric parameters and the IFG-I-IGFBP3 axis between liver and renal transplant children.

机译:肝肾移植儿童的人体测量参数和IFG-I-IGFBP3轴的差异。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Growth can be differently altered after liver and renal transplantation (Tx) in childhood. METHODS: We compared graft function, linear growth, immunosuppression and serum IGF-I (RIA) and IGFBP3 (IRMA) concentrations in 15 liver (5.6+/-1.1 years old) and 17 renal (7.4+/-0.1 years old) Tx patients who were followed for 4-6 years. RESULTS: Graft function was normal post-liver Tx, although in renal recipients creatinine clearance decreased significantly during follow-up. Liver Tx children presented an increase in mean height of 0.92+/-0.2 SDS (P<0.01) beyond the 2nd year post-Tx, although in renal Tx patients height SDS did not improve. Immunosuppressive corticoid dosage could be decreased and discontinued in liver Tx patients, while in renal recipients it was maintained between 0.18+/-0.01 and 0.16+/-0.02 mg/kg/day. At 3.7+/-0.4 years post Tx, liver Tx patients presented higher mean serum IGF-I level, lower mean serum IGFBP3 value, leading to a higher mean IGF-I/IGFBP3 molar ratio, P<0.001. CONCLUSIONS: We found that while catch up growth coud be achieved after liver Tx, height SDS did not improve after renal Tx. This may be related to a reduced renal graft function and/or to differences in immunosuppressive corticoid dosage. In children with renal transplants a challenge for the future will reside in making it possible to substitute steroid therapy without altering graft function.
机译:背景:儿童期肝肾移植(Tx)后生长可能发生不同的变化。方法:我们比较了15个肝脏(5.6 +/- 1.1岁)和17个肾脏(7.4 +/- 0.1岁)Tx中的移植物功能,线性生长,免疫抑制和血清IGF-I(RIA)和IGFBP3(IRMA)浓度随访4-6年的患者。结果:尽管在肾脏接受者中,肌酐清除率在随访期间明显降低,但移植后肝移植后的功能正常。尽管在肾脏Tx患者中,身高SDS并没有改善,但在Tx术后第二年后,肝Tx儿童的平均身高增加了0.92 +/- 0.2 SDS(P <0.01)。肝Tx患者可以降低免疫抑制性皮质激素的剂量并停止使用,而肾脏接受者的剂量维持在0.18 +/- 0.01至0.16 +/- 0.02 mg / kg /天。在Tx术后3.7 +/- 0.4年,肝Tx患者的平均血清IGF-1水平较高,平均血清IGFBP3水平较低,导致平均IGF-1 / IGFBP3摩尔比较高,P <0.001。结论:我们发现,尽管在肝Tx后可达到追赶生长的速度,但在肾脏Tx后身高SDS并没有改善。这可能与肾移植物功能降低和/或免疫抑制性皮质激素剂量的差异有关。对于有肾移植的儿童,未来的挑战将在于在不改变移植物功能的情况下替代类固醇疗法成为可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号